Quercetin Increases the Efficacy of Glioblastoma Treatment Compared to Standard Chemoradiotherapy by the Suppression of PI-3-Kinase-Akt Pathway

REFERENCES

• Nishikawa , R . 2010 . Standard therapy for glioblastoma—a review of where we are . Neurol Med Chir (Tokyo) , 50 : 713 – 719 .
   PubMed Web of Science ®Google Scholar
• Amelio , D , Lorentini , S , Schwarz , M and Amichetti , M . 2010 . Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues . Radiother Oncol , 97 : 361 – 369 .
   PubMed Web of Science ®Google Scholar
• Bidros , D S and Vogelbaum , M A . 2009 . Novel drug delivery strategies in neuro-oncology . Neurotherapeutics , 6 : 539 – 546 .
   PubMed Web of Science ®Google Scholar
• Pozsgai , E , Gomori , E , Szigeti , A , Boronkai , A Gallyas , F Jr. 2007 . Correlation between the progressive cytoplasmic expression of a novel small heat shock protein (Hsp16.2) and malignancy in brain tumors . BMC Cancer , 7 : 233
   PubMed Web of Science ®Google Scholar
• Balmaceda , C . 1998 . Advances in brain tumor chemosensitivity . Curr Opin Oncol , 10 : 194 – 200 .
   PubMedGoogle Scholar
• Murakami , A , Ashida , H and Terao , J . 2008 . Multitargeted cancer prevention by quercetin . Cancer Lett , 269 : 315 – 325 .
   PubMed Web of Science ®Google Scholar
• Ranelletti , F O , Maggiano , N , Serra , F G , Ricci , R Larocca , L M . 2000 . Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors . Int J Cancer , 85 : 438 – 445 .
   PubMed Web of Science ®Google Scholar
• Tang , S N , Singh , C , Nall , D , Meeker , D Shankar , S . 2010 . The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelial-mesenchymal transition . J Mol Signal , 5 : 14
   PubMedGoogle Scholar
• Ferry , D R , Smith , A , Malkhandi , J , Fyfe , D W deTakats , P G . 1996 . Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition . Clin Cancer Res , 2 : 659 – 668 .
   PubMed Web of Science ®Google Scholar
• Jakubowicz-Gil , J , Langner , E and Rzeski , W . 2011 . Kinetic studies of the effects of Temodal and quercetin on astrocytoma cells . Pharmacol Rep , 63 : 403 – 416 .
   PubMed Web of Science ®Google Scholar
• Park , M H and Min do , S . 2011 . Quercetin-induced downregulation of phospholipase D1 inhibits proliferation and invasion in U87 glioma cells . Biochem Biophys Res Commun , 412 : 710 – 715 .
   PubMed Web of Science ®Google Scholar
• Jakubowicz-Gil , J , Langner , E , Wertel , I , Piersiak , T and Rzeski , W . 2010 . Temozolomide, quercetin and cell death in the MOGGCCM astrocytoma cell line . Chem Biol Interact , 188 : 190 – 203 .
   PubMed Web of Science ®Google Scholar
• de Boer , V C , Dihal , A A , van der Woude , H , Arts , I C Wolffram , S . 2005 . Tissue distribution of quercetin in rats and pigs . J Nutr , 135 : 1718 – 1725 .
   PubMed Web of Science ®Google Scholar
• Mosmann , T . 1983 . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cyto-toxicity assays . J Immunol Methods , 65 : 55 – 63 .
   PubMed Web of Science ®Google Scholar
• Vermes , I , Haanen , C , Steffens-Nakken , H and Reutelingsperger , C . 1995 . A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V . J Immunol Methods , 184 : 39 – 51 .
   PubMed Web of Science ®Google Scholar
• Chou , C C , Yang , J S , Lu , H F , Ip , S W Lo , C . 2010 . Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells . Arch Pharm Res , 33 : 1181 – 1191 .
   PubMed Web of Science ®Google Scholar
• Gibellini , L , Pinti , M , Nasi , M , Montagna , J P De Biasi , S . 2011 . Quercetin and cancer chemoprevention . Evid Based Complement Alternat Med , : 591356 2011
   PubMed Web of Science ®Google Scholar
• Staedler , D , Idrizi , E , Kenzaoui , B H and Juillerat-Jeanneret , L . 2011 . Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells . Cancer Chemother Pharmacol , 68 : 1161 – 1172 .
   PubMed Web of Science ®Google Scholar
• Xavier , C P , Lima , C F , Rohde , M and Pereira-Wilson , C . 2011 . Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation . Cancer Chemother Pharmacol , 68 : 1449 – 1457 .
   PubMed Web of Science ®Google Scholar
• Thangasamy , T , Sittadjody , S , Mitchell , G C , Mendoza , E E Radhakrishnan , V M . 2010 . Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73 . BMC Cancer , 10 : 282
   PubMed Web of Science ®Google Scholar
• Jeong , J H , An , J Y , Kwon , Y T , Rhee , J G and Lee , Y J . 2009 . Effects of low dose quercetin: cancer cell-specific inhibition of cell cycle progression . J Cell Biochem , 106 : 73 – 82 .
   PubMed Web of Science ®Google Scholar
• Nair , H K , Rao , K V , Aalinkeel , R , Mahajan , S Chawda , R . 2004 . Inhibition of prostate cancer cell colony formation by the flavonoid quercetin correlates with modulation of specific regulatory genes . Clin Diagn Lab Immunol , 11 : 63 – 69 .
   PubMedGoogle Scholar
• Vargas , A J and Burd , R . 2010 . Hormesis and synergy: pathways and mechanisms of quercetin in cancer prevention and management . Nutr Rev , 68 : 418 – 428 .
   PubMed Web of Science ®Google Scholar
• Plati , J , Bucur , O and Khosravi-Far , R . 2008 . Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities . J Cell Biochem , 104 : 1124 – 1149 .
   PubMed Web of Science ®Google Scholar
• Zamin , L L , Filippi-Chiela , E C , Dillenburg-Pilla , P , Horn , F Salbego , C . 2009 . Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells . Cancer Sci , 100 : 1655 – 1662 .
   PubMed Web of Science ®Google Scholar
• Tapodi , A , Debreceni , B , Hanto , K , Bognar , Z Wittmann , I . 2005 . Pivotal role of Akt activation in mitochondrial protection and cell survival by poly(ADP-ribose)polymerase-1 inhibition in oxidative stress . J Biol Chem , 280 : 35767 – 35775 .
   PubMed Web of Science ®Google Scholar
• Xie , X , Yin , J , Jia , Q , Wang , J Zou , C . 2011 . Quercetin induces apoptosis in the methotrexate-resistant osteosarcoma cell line U2-OS/MTX300 via mitochondrial dysfunction and dephosphorylation of Akt . Oncol Rep , 26 : 687 – 693 .
   PubMed Web of Science ®Google Scholar
• Lee , Y K and Park , O J . 2010 . Regulation of mutual inhibitory activities between AMPK and Akt with quercetin in MCF-7 breast cancer cells . Oncol Rep , 24 : 1493 – 1497 .
   PubMed Web of Science ®Google Scholar
• Lee , M W , Kim , D S , Lee , J H , Lee , B S Lee , S H . 2011 . Roles of AKT1 and AKT2 in non-small cell lung cancer cell survival, growth, and migration . Cancer Sci , 102 : 1822 – 1828 .
   PubMed Web of Science ®Google Scholar
• Zhang , H P , Takayama , K , Su , B , Jiao , X D Li , R . 2011 . Effect of sunitinib combined with ionizing radiation on endothelial cells . J Radiat Res (Tokyo) , 52 : 1 – 8 .
   PubMed Web of Science ®Google Scholar
• Kim , Y H , Lee , D H , Jeong , J H , Guo , Z S and Lee , Y J . 2008 . Quercetin augments TRAIL-induced apoptotic death: involvement of the ERK signal transduction pathway . Biochem Pharmacol , 75 : 1946 – 1958 .
   PubMed Web of Science ®Google Scholar
• Russo , M , Spagnuolo , C , Tedesco , I , Bilotto , S and Russo , G L . 2012 . The flavonoid quercetin in disease prevention and therapy: facts and fancies . Biochem Pharmacol , 83 : 6 – 15 .
   PubMed Web of Science ®Google Scholar
• Lee , Y K , Hwang , J T , Kwon , D Y , Surh , Y J and Park , O J . 2010 . Induction of apoptosis by quercetin is mediated through AMPKalpha1/ASK1/p38 pathway . Cancer Lett , 292 : 228 – 236 .
   PubMed Web of Science ®Google Scholar
• Xavier , C P , Lima , C F , Preto , A , Seruca , R Fernandes-Ferreira , M . 2009 . Luteolin, quercetin and ursolic acid are potent inhibitors of proliferation and inducers of apoptosis in both KRAS and BRAF mutated human colorectal cancer cells . Cancer Lett , 281 : 162 – 170 .
   PubMed Web of Science ®Google Scholar
• Ding , M , Zhao , J , Bowman , L , Lu , Y and Shi , X . 2010 . Inhibition of AP-1 and MAPK signaling and activation of Nrf2/ARE pathway by quercitrin . Int J Oncol , 36 : 59 – 67 .
   PubMed Web of Science ®Google Scholar